OKUR Class A OnKure Therapeutics, Inc. - Class A Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026
$2.56
· of 52w range
· above low
· to high
$2.3452w low
$5.3852w high
P/E
-0.7
EPS
$-4.40
Revenue
$0
your badges
52W Range
$2–$5
Analyst Rating
BUY
Price Target
$16
P/E
-0.7
ROE
-88.6%
Net Profit Margin
-1733.7%
Your badge strip is empty — pin a metric anywhere on this page.
OKUR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.56
P/E
-0.7
EPS
$-4.40
Revenue
$0
ROE
-88.6%
52W Range
$2–$5
OKUR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Oct. 7, 2024 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02024-12-31 → 2024-12-31
EPS$-4.402020-12-31 → 2025-12-31
Free Cash Flow$-52M2021-12-31 → 2025-12-31
Net margin-1733.7%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | OKUR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.75Y avg ≈-10.3 | ≈-10.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | OKUR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -1833.7% | · | -1088.2% | In line | |
| EBITDA Margin | -1820.6% | · | -1088.2% | In line | |
| Net Profit Margin | -1733.7% | · | -988.2% | In line | |
| ROA | -67.2%5Y avg ≈-53.7% | ≈-53.7% | -45.0% | Weak | |
| ROE | -88.6%5Y avg ≈43.4% | ≈43.4% | -103.7% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | OKUR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 26.75Y avg ≈15.2 | ≈15.2 | 10.3 | Strong liquidity | |
| Quick Ratio | 10.05Y avg ≈14.6 | ≈14.6 | 7.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | OKUR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.2 | Weak | |
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
9.0%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.31 | $-0.55 | 43.2% |
| March 31, 2026 | May 12, 2026 | $-1.11 | $-0.76 | -46.6% |
| Dec. 31, 2025 | $-0.99 | $-1.18 | 15.7% | |
| Sept. 30, 2025 | $-1.09 | $-1.22 | 10.8% | |
| June 30, 2025 | $-1.14 | $-1.27 | 10.4% | |
| March 31, 2025 | $-1.19 | $-1.49 | 20.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $0 | |
| R&D Expense | $48M | $44M | |
| SG&A Expense | $15M | $11M | |
| Operating Expenses | $63M | $54M | |
| Operating Income | $-63M | $-54M | |
| Interest Income | $3M | $2M | |
| Income Tax | $0 | $0 | |
| Net Income | $-60M | $-53M | |
| EPS (Basic) | $-4.40 | $-15.28 | |
| EPS (Diluted) | $-4.40 | $-15.28 | |
| Shares (Basic) | 13,515,915 | 3,447,071 | |
| Shares (Diluted) | 13,515,915 | 3,447,071 | |
| EBITDA | $-63M | $-54M |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $59M | $111M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $61M | $113M | |
| PP&E (Net) | $618.0K | $1M | |
| PP&E (Gross) | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | |
| Other Non-current Assets | $273.0K | $109.0K | |
| Total Assets | $62M | $115M | |
| Accounts Payable | $1M | $3M | |
| Accrued Liabilities | · | $7M | |
| Current Liabilities | $6M | $11M | |
| Capital Leases | $0 | $549.0K | |
| Other Non-current Liabilities | $12.0K | · | |
| Total Liabilities | $6M | $11M | |
| Paid-in Capital | $270M | $259M | |
| Retained Earnings | $-214M | $-155M | |
| AOCI | $0 | · | |
| Stockholders' Equity | $56M | $104M | |
| Liabilities + Equity | $62M | $115M |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $447.0K | $459.0K | |
| Stock-based Comp | $12M | $5M | |
| Other Non-cash | $-4M | $-3M | |
| Operating Cash Flow | $-52M | $-51M | |
| CapEx | $46.0K | $52.0K | |
| Investing Cash Flow | $-46.0K | $16M | |
| Financing Cash Flow | $163.0K | $116M | |
| Net Change in Cash | $-52M | $81M | |
| Free Cash Flow | $-52M | $-51M |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1833.7% | · | |
| Net Margin | -1733.7% | · | |
| EBITDA Margin | -1820.6% | · | |
| ROA | -67.2% | -69.9% | |
| ROE | -88.6% | 337.4% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 10.3 | 10.7 | |
| Quick Ratio | 10.0 | 10.5 |
Efficiency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue / Share | $0.25 | $0.00 | |
| Cash Flow / Share | $-3.83 | $-14.83 | |
| EPS (TTM) | $-4.40 | $-15.28 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $0 | |
| Net Income TTM | $-60M | $-53M | |
| P/E | -0.7 | -0.6 | |
| Earnings Yield | -151.7% | -177.7% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $12M | $11M | $12M | $13M | $13M | $14M | $10M | $11M | $9M | $-7M | $14M | $14M | $11M | $10M | $10M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $1M | $4M | $1M | $-14M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $17M | $16M | $14M | $16M | $16M | $17M | $19M | $12M | $14M | $10M | $-21M | $21M | $21M | $16M | $15M | $14M | |
| Operating Income | $-17M | $-16M | $-14M | $-16M | $-16M | $-17M | $-19M | $-12M | $-14M | $-10M | $21M | $-21M | $-21M | $-16M | $-15M | $-14M | |
| Interest Income | $2M | $458.0K | $628.0K | $804.0K | $934.0K | $1M | $1M | $174.0K | $230.0K | $295.0K | · | · | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $972.0K | $1M | $1M | · | $2M | $2M | $1M | $962.0K | $833.0K | |
| Net Income | $-15M | $-15M | $-14M | $-15M | $-15M | $-16M | $-17M | $-12M | $-14M | $-10M | $19M | $-19M | $-20M | $-15M | $-14M | $-13M | |
| EPS (Basic) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| EPS (Diluted) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| Shares (Basic) | 49,869,177 | 13,674,577 | · | 13,530,892 | 13,509,080 | 13,424,335 | · | 316,142 | 315,478 | 314,016 | · | 3,380,794 | 30,215,321 | 25,036,410 | · | 24,496,313 | |
| Shares (Diluted) | 49,869,177 | 13,674,577 | · | 13,530,892 | 13,509,080 | 13,424,335 | · | 316,142 | 315,478 | 314,016 | · | 3,380,794 | 30,215,321 | 25,036,410 | · | 24,496,313 | |
| EBITDA | $-17M | $-16M | · | $-15M | $-16M | $-17M | · | $-5M | $-6M | $-10M | · | $-21M | $-21M | $-16M | · | $-14M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $192M | $59M | $70M | $83M | $97M | $111M | $61M | $36M | $20M | $30M | $12M | $9M | $30M | $20M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | $16M | $41M | $62M | · | $114M | $134M | $63M | $81M | $54M | |
| Prepaid Expense | $1M | $5M | $2M | $1M | $1M | $2M | $2M | $331.0K | $1M | $1M | $4M | $3M | $4M | $3M | $5M | $5M | |
| Current Assets | $178M | $197M | $61M | $72M | $85M | $98M | $113M | $77M | $78M | $84M | $34M | $129M | $146M | $97M | $106M | $121M | |
| PP&E (Net) | $435.0K | $519.0K | $618.0K | $720.0K | $821.0K | $925.0K | $1M | $59.0K | $81.0K | $102.0K | $1M | $529.0K | $554.0K | $581.0K | $453.0K | $241.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | · | · | · | $555.0K | · | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $1M | · | · | · | $665.0K | · | · | · | $102.0K | · | |
| Other Non-current Assets | $401.0K | $405.0K | $273.0K | $104.0K | $116.0K | $109.0K | $109.0K | $147.0K | $153.0K | $64.0K | $58.0K | $81.0K | $79.0K | $81.0K | $84.0K | $79.0K | |
| Total Assets | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Accounts Payable | $2M | $11M | $1M | $1M | $2M | $2M | $3M | $237.0K | $64.0K | $676.0K | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $5M | $6M | · | $725.0K | $953.0K | $2M | $4M | $11M | $12M | $8M | $5M | $7M | |
| Current Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $3M | $1M | $3M | $7M | $14M | $14M | $10M | $7M | $9M | |
| Capital Leases | $590.0K | $0 | · | $120.0K | $267.0K | $409.0K | $549.0K | $379.0K | $492.0K | $576.0K | $466.0K | $812.0K | $897.0K | $979.0K | $1M | $943.0K | |
| Other Non-current Liabilities | $12.0K | $12.0K | $12.0K | $40.0K | $40.0K | $40.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $4M | $2M | $3M | $8M | $15M | $16M | $12M | $8M | $10M | |
| Common Stock | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | · | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $417M | $414M | $270M | $267M | $264M | $261M | $259M | $310M | $309M | $308M | $209.0K | $305M | $304M | $239M | $237M | $235M | |
| Retained Earnings | $-245M | $-229M | $-214M | $-201M | $-186M | $-171M | $-155M | $-236M | $-232M | $-227M | $-102M | $-191M | $-171M | $-152M | $-137M | $-123M | |
| AOCI | $-13.0K | · | · | · | · | · | · | $2.0K | $-13.0K | $-12.0K | · | $-21.0K | $-31.0K | $12.0K | $-43.0K | $-26.0K | |
| Stockholders' Equity | $172M | $184M | $56M | $66M | $78M | $91M | $104M | $74M | $77M | $81M | $-102M | $115M | $133M | $87M | $100M | $112M | |
| Liabilities + Equity | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Shares Outstanding | · | · | · | · | · | · | · | 3,343,525 | 33,420,808 | 33,420,808 | · | 33,872,166 | 33,800,788 | 25,107,430 | 24,699,553 | 24,529,646 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $104.0K | $104.0K | $108.0K | $117.0K | $118.0K | $116.0K | $114.0K | $115.0K | $114.0K | $291.0K | $43.0K | $42.0K | $41.0K | $25.0K | $22.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $-70.0K | $842.0K | $107.0K | $-4M | $1M | $1M | $1M | $1M | $990.0K | |
| Other Non-cash | · | $-665.0K | · | · | · | $-943.0K | · | · | · | $-14M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-10M | $-13M | $-12M | $-13M | $-13M | $-14M | $-23M | $58.0K | $4M | $-11M | $9M | $-19M | $-16M | $-9M | $-16M | $-11M | |
| CapEx | $3.0K | $5.0K | $9.0K | $6.0K | $13.0K | $18.0K | $15.0K | $35.0K | $10.0K | $9.0K | $50.0K | $19.0K | $5.0K | $172.0K | $250.0K | $28.0K | |
| Investing Cash Flow | $-10M | $-5.0K | $-9.0K | $-6.0K | $-13.0K | $-18.0K | $16M | $-36M | $-14M | $-9.0K | $29M | $21M | $-69M | $19M | $-27M | $-45M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-5M | $146M | $240.0K | $0 | $0 | $-77.0K | $110M | $6M | $6M | $10.0K | $-12M | $173.0K | $64M | $1M | $325.0K | $97.0K | |
| Net Change in Cash | $-26M | $133M | $-11M | $-13M | $-13M | $-14M | $103M | $-30M | $-4M | $-11M | $27M | $3M | $-21M | $10M | $-42M | $-56M | |
| Free Cash Flow | · | $-13M | · | · | · | $-14M | · | · | · | · | · | · | · | $-9M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1088.2% | -3409.4% | · | -1932.8% | -1747.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -988.2% | -3309.4% | · | -1832.8% | -1647.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1088.2% | -3386.7% | · | -1919.3% | -1735.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -11.6% | -10.2% | · | -19.5% | -18.7% | -17.3% | · | -3.5% | -4.7% | -9.2% | · | -15.2% | -13.9% | -12.4% | · | -9.1% | |
| ROE | -12.3% | -11.0% | · | -20.9% | -19.9% | -18.5% | · | -3.9% | -5.1% | -10.0% | · | -16.9% | -15.2% | -13.6% | · | -9.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.7 | 13.8 | · | 11.4 | 11.1 | 11.2 | · | 23.7 | 57.9 | 29.8 | · | 9.5 | 10.7 | 9.3 | · | 12.8 | |
| Quick Ratio | 25.1 | 13.4 | · | 11.3 | 11.0 | 11.0 | · | 23.6 | 56.9 | 29.4 | · | 9.3 | 10.4 | 8.9 | · | 12.3 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | $22.14 | $2.30 | $2.43 | · | $3.39 | $3.92 | $3.47 | · | $4.57 | |
| Revenue / Share | $0.03 | $0.03 | · | $0.06 | $0.07 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.95 | · | · | · | $-1.04 | · | · | · | $-0.63 | · | · | · | $-0.36 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | $18.15 | $1.08 | $0.61 | · | $0.35 | $0.27 | $1.21 | · | $2.53 | |
| EPS (TTM) | $-3.49 | $-4.32 | · | $93.04 | $57.58 | $13.90 | · | $-229.22 | $-198.35 | $-154.18 | · | $-7.49 | $-2.34 | $-2.19 | · | $0.68 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-59M | $-59M | · | $-63M | $-60M | $-59M | · | $-17M | $-24M | $-30M | · | $-67M | $-61M | $-54M | · | $-49M | |
| Market Cap | · | · | · | · | · | · | · | $57M | $505M | $555M | · | $2.58B | $2.22B | $1.50B | · | $822M | |
| P/E | -1.3 | -1.0 | · | 0.0 | 0.0 | 0.3 | · | -0.1 | -0.1 | -0.1 | · | -10.2 | -28.0 | -27.3 | · | 49.3 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -26.4 | · | · | · | -165.9 | · | · | |
| Earnings Yield | -76.5% | -104.4% | · | 3383.3% | 2409.2% | 323.3% | · | -1348.3% | -1313.6% | -928.8% | · | -9.8% | -3.6% | -3.7% | · | 2.0% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | $0 | · | · | · |
| Operating Margin % | -1833.7% | · | · | · | · |
| Net Income | $-60M | $-53M | $-35M | $-52M | $-40M |
| Diluted EPS | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.7 | · | 14.9 | 24.8 |
| Quick Ratio | 10.0 | 10.5 | · | 14.2 | 23.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-52M | $-51M | · | $-48M | $-38M |
Institutional owners (13F) 78 filers · $160.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
78
Value held
$160.2M
New positions
32
Exited positions
8
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 32 (+14 vs prior Q) | 8 (+1 vs prior Q) | 21 (+9 vs prior Q) | 9 (-5 vs prior Q) | +4.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18,232,398 | 3,998,333 | 11.38% | Shares |
| BVF INC/IL | $14,755,148 | 3,235,778 | 9.21% | Shares |
| ACORN CAPITAL ADVISORS, LLC | $12,948,913 | 2,839,674 | 8.08% | Shares |
| StepStone Group LP | $11,014,934 | 2,660,612 | 6.88% | Shares |
| ADAR1 Capital Management, LLC | $10,208,399 | 2,238,684 | 6.37% | Shares |
| Vivo Capital, LLC | $8,790,358 | 1,927,710 | 5.49% | Shares |
| Vestal Point Capital, LP | $8,325,187 | 1,825,699 | 5.20% | Shares |
| BlackRock, Inc. | $6,839,294 | 1,499,845 | 4.27% | Shares |
| Trails Edge Capital Partners, LP | $6,559,359 | 1,438,456 | 4.10% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $6,552,898 | 1,437,039 | 4.09% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5,493,975 | 1,204,819 | 3.43% | Shares |
| CITADEL ADVISORS LLC | $5,412,934 | 1,187,047 | 3.38% | Shares |
| Sio Capital Management, LLC | $4,920,080 | 1,078,965 | 3.07% | Shares |
| Prosight Management, LP | $4,464,204 | 978,992 | 2.79% | Shares |
| Logos Global Management LP | $4,395,179 | 963,855 | 2.74% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,303,461 | 724,438 | 2.06% | Shares |
| NEA Management Company, LLC | $2,182,179 | 478,548 | 1.36% | Shares |
| STATE STREET CORP | $2,114,299 | 463,662 | 1.32% | Shares |
| Ensign Peak Advisors, Inc | $1,968,237 | 431,631 | 1.23% | Shares |
| VANGUARD GROUP INC | $1,817,120 | 626,593 | 1.13% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,635,845 | 358,738 | 1.02% | Shares |
| Sofinnova Investments, Inc. | $1,466,916 | 321,692 | 0.92% | Shares |
| Carlyle Group Inc. | $1,230,721 | 269,895 | 0.77% | Shares |
| Seven Fleet Capital Management LP | $1,098,791 | 240,963 | 0.69% | Shares |
| Affinity Asset Advisors, LLC | $1,098,791 | 240,963 | 0.69% | Shares |
| DV EQUITIES, LLC | $1,098,791 | 240,963 | 0.69% | Shares |
| NORTHERN TRUST CORP | $899,127 | 197,177 | 0.56% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $810,613 | 177,766 | 0.51% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $753,207 | 165,177 | 0.47% | Shares |
| MARSHALL WACE, LLP | $729,057 | 159,881 | 0.46% | Shares |
| Rosalind Advisors, Inc. | $684,000 | 150,000 | 0.43% | Shares |
| Stonepine Capital Management, LLC | $595,919 | 130,684 | 0.37% | Shares |
| KOTLER KEVIN | $573,304 | 197,691 | 0.36% | Shares |
| Longaeva Partners L.P. | $549,398 | 120,482 | 0.34% | Shares |
| TWO SIGMA INVESTMENTS, LP | $496,447 | 108,870 | 0.31% | Shares |
| BANK OF AMERICA CORP /DE/ | $484,819 | 106,320 | 0.30% | Shares |
| CANTOR FITZGERALD, L. P. | $456,064 | 100,014 | 0.28% | Shares |
| UBS Group AG | $454,194 | 99,604 | 0.28% | Shares |
| Rangeley Capital, LLC | $433,200 | 95,000 | 0.27% | Shares |
| Aisling Capital Management LP | $404,048 | 88,607 | 0.25% | Shares |
| Bank of New York Mellon Corp | $329,302 | 72,215 | 0.21% | Shares |
| Walleye Capital LLC | $324,230 | 71,103 | 0.20% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $312,453 | 68,563 | 0.20% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $290,198 | 63,640 | 0.18% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $229,336 | 50,293 | 0.14% | Shares |
| Shay Capital LLC | $228,000 | 50,000 | 0.14% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $212,916 | 46,692 | 0.13% | Shares |
| Aldebaran Capital, LLC | $181,803 | 39,869 | 0.11% | Shares |
| WELLS FARGO & COMPANY/MN | $166,217 | 36,451 | 0.10% | Shares |
| Nuveen, LLC | $161,433 | 35,402 | 0.10% | Shares |
Activists & 5%+ owners 10 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik | April 7, 2026 | 19.99% | Initial filing | Passive investment | SEC |
| ACORN BIOVENTURES, L.P., ACORN CAPITAL ADVISORS GP, LLC, Anders Hove, ACORN BIOVENTURES 2, L.P., Acorn Capital Advisors GP 2, LLC ×2 filings | May 30, 2025 | 22.10% | Amendment | M&A / sale | SEC |
| RiverVest Venture Fund III, L.P., RiverVest Venture Fund III (Ohio), L.P., RiverVest Venture Partners III (Ohio), LLC, RiverVest Venture Partners III, L.P., RiverVest Venture Partners III, LLC, RiverVest Venture Fund IV, L.P., RiverVest Venture Partners IV, L.P., RiverVest Venture Partners IV, LLC, John P. McKearn, Ph.D., Jay Schmelter, Thomas C. Melzer, Niall O'Donnell, Ph.D. | Jan. 21, 2025 | 1.55% | Amendment | · | SEC |
| Oct. 8, 2024 | · | Initial filing | · | SEC | |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 filings | May 8, 2024 | · | Initial filing | · | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC | Dec. 26, 2023 | · | Initial filing | Passive investment | SEC |
| Novo Holdings A/S ×5 filings | Dec. 15, 2023 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | May 30, 2023 | · | Initial filing | · | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP | April 20, 2021 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | April 19, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 28 insiders · 10 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nicholas A Saccomano | President and CEO | Sept. 21, 2026 S | 11,160 | 0 | 4 | $-1,252 |
| Gregory J. Flesher | President and CEO | Dec. 9, 2022 A | 109,600 | 0 | 0 | $0 |
| Jason A. Leverone | Chief Financial Officer | Sept. 21, 2026 S | 18,500 | 0 | 4 | $-4,379 |
| Michael Cruse | Chief Operating Officer | Dec. 9, 2022 A | 13,697 | 0 | 0 | $0 |
| Dylan Hartley | Chief Scientific Officer | Aug. 7, 2026 A | · | 0 | 0 | $0 |
| Samuel Agresta | Chief Medical Officer | Aug. 7, 2026 A | · | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | Aug. 28, 2023 M | 39,600 | 0 | 0 | $0 |
| Jennifer Lam | VP of Finance & Administration | Dec. 9, 2022 A | · | 0 | 0 | $0 |
| Alejandro Dorenbaum | Chief Medical Officer | Dec. 9, 2022 A | 30,000 | 0 | 0 | $0 |
| Wendy S. Johnson | Chief Development Officer | July 14, 2021 S | 0 | 0 | 0 | $0 |
| Andrew John Phillips | Director | Aug. 7, 2026 A | · | 0 | 0 | $0 |
| Valerie Malyvanh Jansen | Director | Aug. 7, 2026 A | · | 0 | 0 | $0 |
| Michael R Carruthers | Director | Aug. 7, 2026 A | 4,939 | 0 | 0 | $0 |
| Isaac Manke | Director | Aug. 7, 2026 A | 20,583 | 0 | 0 | $0 |
| Liam Ratcliffe | Director | Aug. 7, 2026 A | · | 0 | 0 | $0 |
| Roshawn A. Blunt | Director | June 6, 2023 A | · | 0 | 0 | $0 |
| Bali Muralidhar | Director | June 6, 2023 A | 2,073,957 | 0 | 0 | $0 |
| Niall O'Donnell, Ph.D. | Director | June 6, 2023 A | 2,188,713 | 0 | 0 | $0 |
| Eric M Dube | Director | June 6, 2023 A | · | 0 | 0 | $0 |
| Stacey Denenberg Seltzer | Director | June 6, 2023 A | · | 0 | 0 | $0 |
| Paul W. Hoelscher | Director | June 6, 2023 A | · | 0 | 0 | $0 |
| Lon Cardon | Director | April 8, 2021 A | · | 0 | 0 | $0 |
| Kenneth Harrison Ph.D. | Director | April 8, 2021 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | 10% owner | June 23, 2023 S | 3,330,337 | 0 | 0 | $0 |
| Edward T. Mathers | · | Aug. 7, 2026 A | 15,310 | 0 | 0 | $0 |
| Michael G Grey | · | Aug. 7, 2026 A | 0 | 0 | 0 | $0 |
| Leonard Braden Michael | · | Oct. 7, 2024 J | 102,076 | 0 | 0 | $0 |
| Vineet R. Jindal | · | Dec. 10, 2021 A | 36,600 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 7 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.02% | 86,965 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 12,539 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.00% | 558,665 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 32,426 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3,580 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 3,221 NS | July 31, 2026 | N-PORT |
| IWN · iShares Trust | · | 226,431 SH | Sept. 11, 2026 | Daily |
OKUR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$15.00
+485.9%
4 33.3%
Strong Buy
6 50.0%
Buy
2 16.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-09-29Mean target $15.50 +505.5%
← Below all targets
Current price $2.56
Low$11.00
Mean$15.50
High$21.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| IMUX | · | -0.9 | · | · | · | · |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 4, 2026